Back

Is regional wall motion abnormality on screening echocardiography prior to trastuzumab therapy a factor influencing left ventricular function?

6 April 2017 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session I - Thursday 08:30 - 18:00 - Risk factors: others_Part 2 Imaging, other EAPC Premium Access EuroPrevent 2017

About the speaker

Photo
Doctor Kalyan Ram Bhamidipati

Whiston Hospital, Prescot (United Kingdom of Great Britain & Northern Ireland)

14 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Associate Professor C. Magri (Msida, MT)
Abstract
Presentation thumbnail
Doctor A. Marzaro (Beirut, LB)
Abstract
Presentation thumbnail
Doctor A. Horina (Graz, AT)
Abstract Slides
Presentation thumbnail
Doctor V. Lisignoli (Rome, IT)
Abstract

Access the full session

Session thumbnail
Poster Session I - Thursday 08:30 - 18:00 - Risk factors: others_Part 2

The Event

Event poster

EuroPrevent 2017

6 April 2017 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources